Embera NeuroTherapeutics, Inc. Company Profile
Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions that drive craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder, Dr. Nicholas Goeders. Embera is advancing EMB-001 development programs in smoking cessation and cocaine dependence based on these results.
News Articles
Embera NeuroTherapeutics Adopts InstantGMP as Their Inventory Control System
Embera NeuroTherapeutics, a specialty pharmaceutical company, needs to closely track their GMP materials. They selected the InstantGMP™ Inventory Control Module for this purpose. Sudbury, MA and Ca...
Remote Tribe Pierces the Darkness with Solar Powered Light From the Grid Earth Project
A remote tribe in the rainforest of Panama is struggling to survive. The Grid Earth Project, http://www.gridearth.org , is pleased to participate in this effort. Austin, Texas (PRWEB) June 29, 2012 R...
Incomplete Conflict of Interest Disclosures: In the Preliminary Communication entitled “Effects of Fructose vs Glucose on Regional Cerebral Blood Flow in Brain Regions Involved With Appetite and Rew...
Combination Therapy in the Treatment of Alzheimer's Disease
Disease-modifying drugs for AD remain elusive, but two classes of symptom-ameliorating drugs -- cholinergic and glutamatergic therapies -- are currently available. Is a combined approach the way forwa...
Psychotherapy in Adult ADHD: Implications for Treatment
This article presents a concise overview of the latest research on various psychotherapeutic interventions for the treatment of adult ADHD. Expert Review of Neurotherapeutics
Neuroperspective reviews status and prospects of therapeutics for Parkinson's disease
NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for...
Study: 10 to 15% of people with TIAs will experience strokes within three months
Each year, as many as 500,000 Americans experience mini strokes called transient ischemic attacks (TIAs). Symptoms quickly go away, usually within an hour, and many people don't seek treatment. But...
Prompt Identification And Therapies Can Improve Outcomes In Perioperative Stroke
Strokes that occur during or shortly after surgery can be devastating, resulting in longer hospital stays and increased risks of death or long-term disability. But prompt identification and treatment...
Drugs and Medications
None
PubMed Articles
Abstracts from the ASENT 14th Annual Meeting.
Mitochondrial Mechanisms and Neurological Disorders.
Erratum to: A Novel "Molecular Tweezer" Inhibitor of α-Synuclein Neurotoxicity In Vitro and In Vivo.
Clinical Trials
None
Companies
Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range...
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a li...
NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorder...
Proneuron Biotechnologies (Israel) Limited
Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzh...
More Information about "Embera NeuroTherapeutics, Inc." on BioPortfolio
We have published hundreds of Embera NeuroTherapeutics, Inc. news stories on BioPortfolio along with dozens of Embera NeuroTherapeutics, Inc. Clinical Trials and PubMed Articles about Embera NeuroTherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embera NeuroTherapeutics, Inc. Companies in our database. You can also find out about relevant Embera NeuroTherapeutics, Inc. Drugs and Medications on this site too.
